The ESCMID Study Group for Clostridioides difficile: History, Role, and Perspectives.
Adv Exp Med Biol
; 1435: 351-362, 2024.
Article
in En
| MEDLINE
| ID: mdl-38175483
ABSTRACT
Clostridioides difficile (C. difficile) is a major nosocomial pathogen but is also increasingly recognised as an important diarrhoeal pathogen in the community, not always associated with antibiotics. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for C. difficile (ESGCD) is a group of clinicians, scientists, and others from many European countries and further afield, who share a common interest in C. difficile. The aims of the Study Group are centred around raising the profile of C. difficile infection (CDI) in humans and animals, fostering collaboration amongst centres in different European countries and providing a forum for discussing and disseminating information. One of the principal aims of the Study Group is to raise awareness of C. difficile infections in Europe. ESGCD has a particular interest in the development and dissemination of European guidance on prevention, diagnosis, and treatment of CDI. This chapter will discuss the organisation of ESGCD within the ESCMID Study Group structure, the origins of the Study Group, the aims, and objectives of the group, and will highlight some of the past and present activities of ESGCD in relation to these.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Communicable Diseases
/
Clostridioides difficile
Type of study:
Guideline
Limits:
Animals
/
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Adv Exp Med Biol
Year:
2024
Type:
Article
Affiliation country:
Denmark